Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith A Baggerly

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 27, 2015
Intratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma: challenges for personalized therapyRajesh R Singh, Paari Murugan, Lalit R Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2013
Targeting SRC and tubulin in mucinous ovarian carcinomaTao Liu, Wei Hu, Heather J Dalton, et al.
Journal of the National Cancer Institute|September 30, 2011
Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell deathAlpa M Nick, Rebecca L Stone, Guillermo Armaiz-Pena, et al.
Oncotarget|December 13, 2017
Macrophage depletion through colony stimulating factor 1 receptor pathway blockade overcomes adaptive resistance to anti-VEGF therapyYasmin A Lyons, Sunila Pradeep, Sherry Y Wu, et al.
Nature Medicine|February 1, 2002
Steps toward mapping the human vasculature by phage displayWadih Arap, Mikhail G Kolonin, Martin Trepel, et al.
Cancer Research|April 19, 2014
Notch3 pathway alterations in ovarian cancerWei Hu, Tao Liu, Cristina Ivan, et al.
Journal of the National Cancer Institute|January 29, 2016
Role of Increased n-acetylaspartate Levels in CancerBehrouz Zand, Rebecca A Previs, Niki M Zacharias, et al.
Nature Communications|September 11, 2013
Tumour angiogenesis regulation by the miR-200 familyChad V Pecot, Rajesha Rupaimoole, Da Yang, et al.
Nature Communications|April 5, 2016
A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancerSherry Y Wu, Rajesha Rupaimoole, Fangrong Shen, et al.
Nature Communications|March 13, 2014
2'-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activitySherry Y Wu, Xianbin Yang, Kshipra M Gharpure, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 27, 2015
Intratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma: challenges for personalized therapyRajesh R Singh, Paari Murugan, Lalit R Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2013
Targeting SRC and tubulin in mucinous ovarian carcinomaTao Liu, Wei Hu, Heather J Dalton, et al.
Journal of the National Cancer Institute|September 30, 2011
Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell deathAlpa M Nick, Rebecca L Stone, Guillermo Armaiz-Pena, et al.
Oncotarget|December 13, 2017
Macrophage depletion through colony stimulating factor 1 receptor pathway blockade overcomes adaptive resistance to anti-VEGF therapyYasmin A Lyons, Sunila Pradeep, Sherry Y Wu, et al.
Nature Medicine|February 1, 2002
Steps toward mapping the human vasculature by phage displayWadih Arap, Mikhail G Kolonin, Martin Trepel, et al.
Cancer Research|April 19, 2014
Notch3 pathway alterations in ovarian cancerWei Hu, Tao Liu, Cristina Ivan, et al.
Journal of the National Cancer Institute|January 29, 2016
Role of Increased n-acetylaspartate Levels in CancerBehrouz Zand, Rebecca A Previs, Niki M Zacharias, et al.
Nature Communications|September 11, 2013
Tumour angiogenesis regulation by the miR-200 familyChad V Pecot, Rajesha Rupaimoole, Da Yang, et al.
Nature Communications|April 5, 2016
A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancerSherry Y Wu, Rajesha Rupaimoole, Fangrong Shen, et al.
Nature Communications|March 13, 2014
2'-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activitySherry Y Wu, Xianbin Yang, Kshipra M Gharpure, et al.
Pageof 10